Reply from Hong-Sheng Wang

Wang and Brady Reply.

Reply to Wang and Zhang.

1. An additional updated literature search had been conducted by the authors (D. Menzies and H. Hussain) to identify additional studies that had been published since the last systematic review and might otherwise have been included in the individual patient data (IPD). Of 523 titles identified, 30 were selected for full text review. Thirteen were additional reports on the cohorts that were alre...

Reply to Wang and Liang.

TO THE EDITOR—We thank Drs Wang and Liang for their comments. Mass drug administration (MDA) is not sustainable even in the short term and should not be advocated. Numerous epidemiological studies from around the world, dating back to the early 1980s, have shown that the impact of praziquantel on the prevalence, intensity, and morbidity of disease is short-lived and that in highly endemic areas...

Reply to Hong et al.

TO THE EDITOR—We thank Hong and colleagues [1] for their interest in our work [2]. We agree that the T-SPOT.TB test is likely to be less affected by lymphocytopenia or immunosuppression than the QuantiFERON-TB Gold In-Tube (QFTGIT) test. It is possible that the extremely low number (n = 3) of negative results contributed to their finding that lymphocytopenia or ground glass opacity (GGO) on com...

Hong Et Al. Reply to Walliser

We find it absurd that Walliser [1] essentially used the same analysis and obtained identical results as reported in [3], yet arrived at different conclusions. Namely, based on an incomplete theory and using erroneous arguments , he not only disputes the original results [2], but also claims them wrong. A more complete theory and much more detailed studies were published in [3], from which we c...